Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iRadimed Corporation (IRMD : NSDQ)
 
 • Company Description   
iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.

Number of Employees: 160

 
 • Price / Volume Information   
Yesterday's Closing Price: $71.27 Daily Weekly Monthly
20 Day Moving Average: 39,449 shares
Shares Outstanding: 12.72 (millions)
Market Capitalization: $906.20 (millions)
Beta: 1.02
52 Week High: $74.43
52 Week Low: $46.86
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.60% -0.19%
12 Week 21.93% 10.76%
Year To Date 29.58% 20.57%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
12705 Ingenuity Drive
-
Orlando,FL 32826
USA
ph: 407-677-8022
fax: 407-677-5037
investorrelations@iradimed.com http://www.iradimed.com
 
 • General Corporate Information   
Officers
Roger Susi - Chairman; Chief Executive Officer and President
John Glenn - Chief Financial Officer and Secretary
Monty Allen - Director
Anthony Vuoto - Director
James Hawkins - Director

Peer Information
iRadimed Corporation (ABMD)
iRadimed Corporation (DMDS)
iRadimed Corporation (CPWY.)
iRadimed Corporation (EQUR)
iRadimed Corporation (ECIA)
iRadimed Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 46266A109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 10/30/25
Share - Related Items
Shares Outstanding: 12.72
Most Recent Split Date: (:1)
Beta: 1.02
Market Capitalization: $906.20 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.95%
Current Fiscal Quarter EPS Consensus Estimate: $0.43 Indicated Annual Dividend: $0.68
Current Fiscal Year EPS Consensus Estimate: $1.72 Payout Ratio: 0.42
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.27
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 08/18/2025 - $0.17
Next EPS Report Date: 10/30/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 41.44
Trailing 12 Months: 43.99
PEG Ratio: -
Price Ratios
Price/Book: 9.61
Price/Cash Flow: 45.04
Price / Sales: 11.67
EPS Growth
vs. Year Ago Period: 18.42%
vs. Previous Quarter: 21.62%
Sales Growth
vs. Year Ago Period: 13.83%
vs. Previous Quarter: 4.60%
ROE
06/30/25 - 23.30
03/31/25 - 23.28
12/31/24 - 23.60
ROA
06/30/25 - 20.62
03/31/25 - 20.59
12/31/24 - 20.76
Current Ratio
06/30/25 - 8.78
03/31/25 - 8.87
12/31/24 - 8.84
Quick Ratio
06/30/25 - 7.51
03/31/25 - 7.62
12/31/24 - 7.62
Operating Margin
06/30/25 - 26.61
03/31/25 - 26.32
12/31/24 - 26.26
Net Margin
06/30/25 - 26.61
03/31/25 - 26.33
12/31/24 - 26.26
Pre-Tax Margin
06/30/25 - 33.53
03/31/25 - 33.23
12/31/24 - 33.14
Book Value
06/30/25 - 7.41
03/31/25 - 7.08
12/31/24 - 6.85
Inventory Turnover
06/30/25 - 1.65
03/31/25 - 1.57
12/31/24 - 1.46
Debt-to-Equity
06/30/25 - 0.00
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - 0.00
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©